This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Celator Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops therapies to treat cancer.View CPXX key stats
Celator Pharmaceuticals Inc - CPXX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Celator Pharmaceuticals Inc as a
Sell with a ratings score of E+.
Report Snippet: We rate CELATOR PHARMACEUTICALS INC (CPXX) a SELL. This is based on a variety of negative investment measures, which should drive this stock to significantly underperform the majority of stocks that we rate. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.